Vyome Holdings (HIND) Invested Capital (2015 - 2025)
Vyome Holdings (HIND) posted quarterly Invested Capital of $4.0 million for Q2 2025, up 19.48% year-over-year from $3.4 million in Q2 2024, and up 12.55% quarter-over-quarter from $3.6 million in Q4 2024.
Vyome Holdings (HIND) Invested Capital (2015 - 2025) Analysis & Trends
Vyome Holdings' Invested Capital history runs 9 years deep, the most recent figure standing at $4.0 million for Q2 2025.
- In Q2 2025, Invested Capital rose 19.48% year-over-year to $4.0 million; the TTM figure through Mar 2026 stood at $4.0 million (down 42.04% YoY), while the FY2024 annual figure was $3.6 million, up 22.47% from the prior year.
- Invested Capital for Q2 2025 stood at $4.0 million, up from $3.6 million in the prior quarter.
- The five-year high for Invested Capital was $4.0 million in Q2 2025, with the low at $430000.0 in Q1 2021.
- The 4-year median for Invested Capital is $3.0 million (2021), against an average of $2.9 million.
- The sharpest annual moves came in 2024 and 2025: Invested Capital climbed 22.47% in 2024, then grew 19.48% in 2025.
- Vyome Holdings' Invested Capital stood at $3.0 million in 2021, then retreated by 1.35% to $2.9 million in 2023, then climbed by 22.47% to $3.6 million in 2024, then advanced by 12.55% to $4.0 million in 2025.
- Business Quant data shows HIND's Invested Capital at $4.0 million in Q2 2025, $3.6 million in Q4 2024, and $3.4 million in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 37.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 190.90 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 1.45 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 380.00 Mn |
| 10 | Vyome Holdings | 16.07 Mn | 8.18 Mn | 11,658.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 4.04 Mn |
| Dec 31, 2024 | 3.59 Mn |
| Jun 30, 2024 | 3.38 Mn |
| Dec 31, 2023 | 2.93 Mn |
| Sep 30, 2021 | 2.97 Mn |
| Jun 30, 2021 | 2.94 Mn |
| Mar 31, 2021 | 430,000.00 |
| Dec 31, 2020 | 3.61 Mn |
| Jun 30, 2019 | 5.00 Mn |
| Mar 31, 2019 | 19.95 Mn |
| Dec 31, 2018 | 9.93 Mn |
| Sep 30, 2018 | 523,000.00 |
| Jun 30, 2018 | 3.97 Mn |
| Mar 31, 2018 | 2.96 Mn |
| Dec 31, 2017 | 1.96 Mn |
| Sep 30, 2017 | 957,000.00 |
| Dec 31, 2015 | 747,000.00 |